<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04221737</url>
  </required_header>
  <id_info>
    <org_study_id>HCG/CEI-0632/17</org_study_id>
    <nct_id>NCT04221737</nct_id>
  </id_info>
  <brief_title>Early Use of Airway Pressure Release Ventilation (APRV) in ARDS</brief_title>
  <official_title>Early Use of Airway Pressure Release Ventilation (APRV) in Patients With Acute Respiratory Distress Syndrome</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Civil de Guadalajara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Civil de Guadalajara</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Airway pressure release ventilation (APRV) is a time-cycled, pressure controlled,
      intermittent mandatory ventilation mode with extreme inverse I:E ratios. Currently it is
      considered as a non-conventional ventilatory mode. The investigators aim to compare APRV with
      conventional mechanical ventilation (MV) in patients with acute respiratory distress syndrome
      (ARDS).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Despite the advances in technology and ventilatory modes, mortality of ARDS is still around
      40%. Besides prone positioning, the best approach of management is low tidal volume
      ventilation (LTV). This 'protective ventilation' strategy is not aways effective to improve
      oxygenation and is associated with an increased requirement of sedation and neuromuscular
      blocking agents, which increase length of stay and morbidity. APRV is a ventilatory mode
      based on relatively high and sustained continuous positive pressure, combined with a short
      phase of release to allow carbon dioxide removal. It also allows unrestricted spontaneous
      breathing throughout respiration, independent of the ventilator cycle. Providing sustained
      inflation while limiting duration and frequency of release phase permits limiting volume
      loss, resulting in progressive and improved alveolar recruitment, an increased alveolar
      surface area available for gas exchange and improved ventilation-perfusion matching.

      In this multi-center, prospective, randomized, controlled, open trial, the investigators aim
      to compare the effects and safety of the early application of time-controlled adaptive method
      of APRV and conventional ventilation with LTV strategy in patients with severe to moderate
      ARDS.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">July 15, 2017</start_date>
  <completion_date type="Anticipated">January 2026</completion_date>
  <primary_completion_date type="Anticipated">November 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Mechanical ventilation free days</measure>
    <time_frame>28 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>All causes mortality</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>ICU length of stay</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Hospital length of stay</measure>
    <time_frame>60 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean airway pressure, peak airway pressure, maximum P high</measure>
    <time_frame>7 days</time_frame>
    <description>Measured in cmH20</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average expiratory time</measure>
    <time_frame>7 days</time_frame>
    <description>Measured in seconds</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Minute ventilation</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>oxygen partial pressure (pO2)</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>pCO2 (carbon dioxide partial pressure)</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mean arterial pressure</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Maximum dosage of vasopressors requirement</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Richmond Sedation-Agitation Scale</measure>
    <time_frame>7 days</time_frame>
    <description>Range from -5 (unarousable) to +4 (combative)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average dose of propofol use</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of neuromuscular blocking agents utilization</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Prone position rate</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Average of prone position sessions</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Rate of recruitment maneuvers</measure>
    <time_frame>7 days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Tracheostomy rate</measure>
    <time_frame>28 days</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">150</enrollment>
  <condition>Acute Respiratory Distress Syndrome</condition>
  <arm_group>
    <arm_group_label>Conventional ventilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Protective lung conventional strategy with volume-controlled ventilation (VCV) or pressure-controlled ventilation (PCV) mode, with low tidal volume and adequate positive end expiratory pressure (PEEP) level.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Time-controlled adaptive APRV</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Airway Pressure Release Ventilation with Time-controlled adaptive ventilation method. Allowing for spontaneous breathing.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>APRV. General Electric Healthcare Engstrom ventilator system</intervention_name>
    <description>APRV consist of an extended time at plateau pressure (a continuous positive airway pressure phase) comprising about 90% of the respiratory cycle, while providing very brief releases to enhance carbon dioxide removal. Time-controlled adaptive method requires interpretation of the expiratory flow curve to assess changes in lung elastance and, therefore, set the Time low to optimize carbon dioxide removal, but not at the expense of alveolar derecruitment and instability.</description>
    <arm_group_label>Time-controlled adaptive APRV</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Conventional. General Electric Healthcare Engstrom ventilator system</intervention_name>
    <description>Lung protective ventilation consist of delivery of low tidal volumes (4-6 ml/kg PBW), high PEEP enough to avoid de-recruitment, titrated according to ARDSNet PEEP/fraction of inspired oxygen (FiO2) table, while avoiding excessive transpulmonary pressure.</description>
    <arm_group_label>Conventional ventilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Acute respiratory distress syndrome, according to the Berlin definition of ARDS, with
             adjusted pO2/FiO2 for altitude &lt;300, and less than 48 h of endotracheal mechanical
             ventilation

        Exclusion Criteria:

          -  Pregnancy

          -  Less than 18 years-old

          -  Expected duration of mechanical ventilation less than 48 h

          -  Preexisting conditions with an expected 3-month mortality exceeding 50%

          -  Concurrent chemotherapy

          -  Confirmed intracranial hypertension

          -  Catastrophic cranial trauma or neuromuscular disorders that are known to prolong
             mechanical ventilation

          -  Pneumothorax at enrollment (resolved or not)

          -  Do-not-resuscitate order
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miguel Ibarra-Estrada, Dr</last_name>
    <role>Principal Investigator</role>
    <affiliation>Hospital Civil Fray Antonio Alcalde</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Miguel Ibarra-Estrada, Dr</last_name>
    <phone>3317593502</phone>
    <email>drmiguelibarra@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Guadalupe Aguirre-Avalos, Dr</last_name>
    <email>guadalupe.aavalos@academicos.udg.mx</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Hospital Civil Fray Antonio Alcalde</name>
      <address>
        <city>Guadalajara</city>
        <state>Jalisco</state>
        <zip>44280</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Miguel Ibarra, Dr</last_name>
      <phone>3317593502</phone>
      <email>drmiguelibarra@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Guadalupe Aguirre, Dr</last_name>
      <email>guadalupe.aavalos@academicos.udg.mx</email>
    </contact_backup>
    <investigator>
      <last_name>Guadalupe Aguirre-Avalos, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Yessica García-Salas, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Quetzalcóatl Chávez-Peña, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Arnulfo López-Pulgarín, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Lopez Saubidet I, Maskin LP, Rodríguez PO, Bonelli I, Setten M, Valentini R. Mortality in patients with respiratory distress syndrome. Med Intensiva. 2016 Aug-Sep;40(6):356-63. doi: 10.1016/j.medin.2015.10.007. Epub 2015 Dec 31. English, Spanish.</citation>
    <PMID>26746127</PMID>
  </reference>
  <reference>
    <citation>Guérin C, Reignier J, Richard JC, Beuret P, Gacouin A, Boulain T, Mercier E, Badet M, Mercat A, Baudin O, Clavel M, Chatellier D, Jaber S, Rosselli S, Mancebo J, Sirodot M, Hilbert G, Bengler C, Richecoeur J, Gainnier M, Bayle F, Bourdin G, Leray V, Girard R, Baboi L, Ayzac L; PROSEVA Study Group. Prone positioning in severe acute respiratory distress syndrome. N Engl J Med. 2013 Jun 6;368(23):2159-68. doi: 10.1056/NEJMoa1214103. Epub 2013 May 20.</citation>
    <PMID>23688302</PMID>
  </reference>
  <reference>
    <citation>Acute Respiratory Distress Syndrome Network, Brower RG, Matthay MA, Morris A, Schoenfeld D, Thompson BT, Wheeler A. Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med. 2000 May 4;342(18):1301-8.</citation>
    <PMID>10793162</PMID>
  </reference>
  <reference>
    <citation>Albert S, Kubiak BD, Vieau CJ, Roy SK, DiRocco J, Gatto LA, Young JL, Tripathi S, Trikha G, Lopez C, Nieman GF. Comparison of &quot;open lung&quot; modes with low tidal volumes in a porcine lung injury model. J Surg Res. 2011 Mar;166(1):e71-81. doi: 10.1016/j.jss.2010.10.022. Epub 2010 Nov 12.</citation>
    <PMID>21195426</PMID>
  </reference>
  <reference>
    <citation>Sydow M, Burchardi H, Ephraim E, Zielmann S, Crozier TA. Long-term effects of two different ventilatory modes on oxygenation in acute lung injury. Comparison of airway pressure release ventilation and volume-controlled inverse ratio ventilation. Am J Respir Crit Care Med. 1994 Jun;149(6):1550-6.</citation>
    <PMID>8004312</PMID>
  </reference>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>January 5, 2020</study_first_submitted>
  <study_first_submitted_qc>January 6, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 9, 2020</study_first_posted>
  <last_update_submitted>January 9, 2020</last_update_submitted>
  <last_update_submitted_qc>January 9, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 13, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Civil de Guadalajara</investigator_affiliation>
    <investigator_full_name>Miguel Á Ibarra-Estrada</investigator_full_name>
    <investigator_title>Principal investigator</investigator_title>
  </responsible_party>
  <keyword>Acute Respiratory Distress Syndrome</keyword>
  <keyword>Acute Lung Injury</keyword>
  <keyword>Mechanical Ventilation</keyword>
  <keyword>APRV</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Respiratory Distress Syndrome, Newborn</mesh_term>
    <mesh_term>Respiratory Distress Syndrome, Adult</mesh_term>
    <mesh_term>Acute Lung Injury</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

